UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Operating Income Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual operating income in 2023 was -96.28 Million TWD , up 8.06% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -25.58 Million TWD , down -0.1% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported an annual operating income of -89.89 Million TWD in 2022, down -4.88% from previous year.
  • UnicoCell Biomed Co., Ltd. reported an annual operating income of -85.71 Million TWD in 2021, up 20.83% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a quarterly operating income of -31.13 Million TWD for 2024 Q1, down -12.75% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a quarterly operating income of -27.61 Million TWD for 2023 Q3, down -81.45% from previous quarter.

Annual Operating Income Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -96.28 Million TWD 8.06%
2022 -89.89 Million TWD -4.88%
2021 -85.71 Million TWD 20.83%
2020 -108.26 Million TWD -7.15%
2019 -101.04 Million TWD 0.0%

Peer Operating Income Comparison of UnicoCell Biomed Co., Ltd.

Name Operating Income Operating Income Difference
Apex Biotechnology Corp. 141.71 Million TWD 167.939%
Sinphar Pharmaceutical Co.,Ltd. 286.05 Million TWD 133.658%
Panion & Bf Biotech Inc. 156.82 Million TWD 161.392%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 280.8 Million TWD 134.287%
GenMont Biotech Incorporation 6.98 Million TWD 1477.79%
Abnova (Taiwan) Corporation 47.19 Million TWD 304.009%
Adimmune Corporation -722.74 Million TWD 86.679%
Tanvex BioPharma, Inc. -2.1 Billion TWD 95.417%
Polaris Group -1.84 Billion TWD 94.787%
Energenesis Biomedical CO.,LTD. -261.83 Million TWD 63.229%
PELL Bio-Med Technology Co. Ltd. -411.24 Million TWD 76.588%